Toggle sidebar
Toggle sidebar
全部
R1
智能回答
Search
Search
定价
登录
Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
Actuate Therapeutics,Inc(ACTU)
GlobeNewswire
·
2025-04-17 20:00